| Kimberly Ann Cox, MD | |
|
2114 Gault Ave N, Fort Payne, AL 35967-3534 | |
| (256) 845-4000 | |
| Not Available |
| Full Name | Kimberly Ann Cox |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 2114 Gault Ave N, Fort Payne, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588759633 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 23680 (Alabama) | Secondary |
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 23680 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Family Care, Inc. | 9739087818 | 179 |
News Archive
The GOP candidate's positions are not a vision of the future for the U.S. but of a discredited past. ... Perry's proposed fixes for the healthcare system -; tort reform, individual ownership of health insurance, portability of plans for people who move or change jobs -; would do nothing to slow the growth of healthcare costs or reduce the number of uninsured Americans.
The debate between good fat versus bad fat continues, as a new evidence review finds that a modified fat diet — and not a low fat diet — might be the real key to reducing one's risk of heart disease.
Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT) products for cancer, today announced that the U.S. Food and Drug Administration Office of Orphan Products Development granted orphan drug designation for the Company's lead investigational therapy, an autologous engineered T cell product that targets CD19 expression on B cell malignancies, for the treatment of diffuse large B cell lymphoma (DLBCL).
In the United States, a baby is born with a facial cleft every hour, of every day of the year! Such birth defects result from both gene mutations and environmental insults. PRDM16 is a transcription factor originally described as being aberrantly activated in specific types of leukemia's, and more recently as a master regulator of brown adipose tissue differentiation.
Mary Ann Liebert, Inc., publishers is pleased to announce Drug Repurposing, Rescue, and Repositioning, a dynamic new peer-reviewed journal that will present techniques and tools for finding new uses for approved drugs—particularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified.
› Verified 8 days ago
| Entity Name | American Family Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429080 PECOS PAC ID: 9739087818 Enrollment ID: O20031229000157 |
News Archive
The GOP candidate's positions are not a vision of the future for the U.S. but of a discredited past. ... Perry's proposed fixes for the healthcare system -; tort reform, individual ownership of health insurance, portability of plans for people who move or change jobs -; would do nothing to slow the growth of healthcare costs or reduce the number of uninsured Americans.
The debate between good fat versus bad fat continues, as a new evidence review finds that a modified fat diet — and not a low fat diet — might be the real key to reducing one's risk of heart disease.
Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT) products for cancer, today announced that the U.S. Food and Drug Administration Office of Orphan Products Development granted orphan drug designation for the Company's lead investigational therapy, an autologous engineered T cell product that targets CD19 expression on B cell malignancies, for the treatment of diffuse large B cell lymphoma (DLBCL).
In the United States, a baby is born with a facial cleft every hour, of every day of the year! Such birth defects result from both gene mutations and environmental insults. PRDM16 is a transcription factor originally described as being aberrantly activated in specific types of leukemia's, and more recently as a master regulator of brown adipose tissue differentiation.
Mary Ann Liebert, Inc., publishers is pleased to announce Drug Repurposing, Rescue, and Repositioning, a dynamic new peer-reviewed journal that will present techniques and tools for finding new uses for approved drugs—particularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified.
› Verified 8 days ago
| Entity Name | Graceful Gynecology, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972935898 PECOS PAC ID: 9234363607 Enrollment ID: O20131018000480 |
News Archive
The GOP candidate's positions are not a vision of the future for the U.S. but of a discredited past. ... Perry's proposed fixes for the healthcare system -; tort reform, individual ownership of health insurance, portability of plans for people who move or change jobs -; would do nothing to slow the growth of healthcare costs or reduce the number of uninsured Americans.
The debate between good fat versus bad fat continues, as a new evidence review finds that a modified fat diet — and not a low fat diet — might be the real key to reducing one's risk of heart disease.
Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT) products for cancer, today announced that the U.S. Food and Drug Administration Office of Orphan Products Development granted orphan drug designation for the Company's lead investigational therapy, an autologous engineered T cell product that targets CD19 expression on B cell malignancies, for the treatment of diffuse large B cell lymphoma (DLBCL).
In the United States, a baby is born with a facial cleft every hour, of every day of the year! Such birth defects result from both gene mutations and environmental insults. PRDM16 is a transcription factor originally described as being aberrantly activated in specific types of leukemia's, and more recently as a master regulator of brown adipose tissue differentiation.
Mary Ann Liebert, Inc., publishers is pleased to announce Drug Repurposing, Rescue, and Repositioning, a dynamic new peer-reviewed journal that will present techniques and tools for finding new uses for approved drugs—particularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Ann Cox, MD 2114 Gault Ave N, Fort Payne, AL 35967-3534 Ph: (256) 845-4000 | Kimberly Ann Cox, MD 2114 Gault Ave N, Fort Payne, AL 35967-3534 Ph: (256) 845-4000 |
News Archive
The GOP candidate's positions are not a vision of the future for the U.S. but of a discredited past. ... Perry's proposed fixes for the healthcare system -; tort reform, individual ownership of health insurance, portability of plans for people who move or change jobs -; would do nothing to slow the growth of healthcare costs or reduce the number of uninsured Americans.
The debate between good fat versus bad fat continues, as a new evidence review finds that a modified fat diet — and not a low fat diet — might be the real key to reducing one's risk of heart disease.
Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT) products for cancer, today announced that the U.S. Food and Drug Administration Office of Orphan Products Development granted orphan drug designation for the Company's lead investigational therapy, an autologous engineered T cell product that targets CD19 expression on B cell malignancies, for the treatment of diffuse large B cell lymphoma (DLBCL).
In the United States, a baby is born with a facial cleft every hour, of every day of the year! Such birth defects result from both gene mutations and environmental insults. PRDM16 is a transcription factor originally described as being aberrantly activated in specific types of leukemia's, and more recently as a master regulator of brown adipose tissue differentiation.
Mary Ann Liebert, Inc., publishers is pleased to announce Drug Repurposing, Rescue, and Repositioning, a dynamic new peer-reviewed journal that will present techniques and tools for finding new uses for approved drugs—particularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified.
› Verified 8 days ago
Warren W. Scott, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 550 Medical Center Dr Sw, Fort Payne, AL 35968 Phone: 256-845-8885 Fax: 256-845-9546 | |
John Blakely Isbell, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 550 Medical Center Dr Sw, Fort Payne, AL 35968 Phone: 256-845-8885 Fax: 256-845-9546 | |
Robert C Raymond, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2615 Gault Ave N, Fort Payne, AL 35967 Phone: 256-845-4134 Fax: 256-845-4709 | |
Kristopher Ross Weemes, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 550 Medical Center Dr Sw, Fort Payne, AL 35968 Phone: 256-845-8885 Fax: 256-845-9546 |